Abstract
Two closely related classes of oxindole-based compounds, 1H-indole-2,3-dione 3-phenylhydrazones and 3-(anilinomethylene)-1,3-dihydro-2H-indol-2-ones, were shown to potently inhibit cyclin-dependent kinase 2 (CDK2). The initial lead compound was prepared as a homologue of the 3-benzylidene-1,3-dihydro-2H-indol-2-one class of kinase inhibitor. Crystallographic analysis of the lead compound bound to CDK2 provided the basis for analogue design. A semiautomated method of ligand docking was used to select compounds for synthesis, and a number of compounds with low nanomolar inhibitory activity versus CDK2 were identified. Enzyme binding determinants for several analogues were evaluated by X-ray crystallography. Compounds in this series inhibited CDK2 with a potency approximately 10-fold greater than that for CDK1. Members of this class of inhibitor cause an arrest of the cell cycle and have shown potential utility in the prevention of chemotherapy-induced alopecia.
MeSH terms
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology
-
CDC2-CDC28 Kinases*
-
Crystallography, X-Ray
-
Cyclin-Dependent Kinase 2
-
Cyclin-Dependent Kinases / antagonists & inhibitors*
-
Drug Screening Assays, Antitumor
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
G1 Phase / drug effects
-
Humans
-
Hydrazones / chemical synthesis*
-
Hydrazones / chemistry
-
Hydrazones / pharmacology
-
Indoles / chemical synthesis*
-
Indoles / chemistry
-
Indoles / pharmacology
-
Isatin / analogs & derivatives
-
Isatin / chemical synthesis
-
Isatin / chemistry
-
Models, Molecular
-
Protein Binding
-
Protein Serine-Threonine Kinases / antagonists & inhibitors*
-
S Phase / drug effects
-
Stereoisomerism
-
Structure-Activity Relationship
-
Sulfonamides / chemistry
-
Tumor Cells, Cultured
Substances
-
Antineoplastic Agents
-
Enzyme Inhibitors
-
Hydrazones
-
Indoles
-
Sulfonamides
-
Isatin
-
Protein Serine-Threonine Kinases
-
CDC2-CDC28 Kinases
-
CDK2 protein, human
-
Cyclin-Dependent Kinase 2
-
Cyclin-Dependent Kinases